Abstract
Introduction
As endovascular therapies for intracranial aneurysms continue to evolve, the need for more stable and reliable access support systems to the cerebral vasculature has become increasingly important. The access techniques of modern neurointerventional procedures for many operators have shifted from biaxial to triaxial systems. Flow diverters such as the Pipeline Flex embolization device (PED Flex; Medtronic Neurovascular) and the Surpass flow diverter (Stryker Neurovascular, Fremont, CA, USA), as well as flow disruptors such as the Woven EndoBridge Device (MicroVention/Sequent Medical, Tustin, CA, USA), have necessitated this shift. In conjunction with the development and introduction of these new devices, a new category of intracranial catheters, distal intracranial catheters (DICs) or intermediate catheters (ICs) , has emerged to provide robust distal intracranial support. This support is vitally important for the delivery of flow diverters [1] and flow disruptors, which utilize larger microcatheters than the traditional microcatheters for the delivery of coils or adjunctive devices [1] .
DICs were designed with the flexibility to navigate the distal intracranial circulation safely while providing support for enhanced microcatheter control [1] . Initial catheters such as the Outreach and Neuron were successful in navigating into the proximal intracranial vasculature, inching the guide catheter support from a cervical location closer to distal intracranial locations [2] [3] [4] . With the introduction of the Navien (Medtronic Neurovascular), a 5-or 6-Fr intracranial catheter support in distal intracranial locations of both the anterior and posterior circulations became routine [5] [6] [7] . The AXS Catalyst 5 (Stryker Neurovascular) is a next-generation multi-durometer DIC incorporating design modifications to maximize robust support and atraumatic navigation [8] .
The Syphontrak (Codman Neuro, Raynham, MA, USA) is the newest addition to the DIC family of catheters for neurointervention. In this report we present our initial experiences using the Syphontrak in PED Flex flow diversion cases.
Methods

Patient Selection
We retrospectively reviewed a prospective, single-center aneurysm database identifying all patients undergoing Pipeline Flex embolization for treatment of cerebral aneurysms using the Syphontrak from August 2016 (first availability of the catheter at our institution) to June 2017.
All procedures were performed at either the Johns Hopkins Hospital or the Johns Hopkins Bayview Medical Center (both in Baltimore, MD, USA).
Data Collection and Analysis
Data on patient demographics, aneurysm size, vessel tortuosity, vasodilator use, fluoroscopy time, procedural equipment, technical details, and periprocedural complications related to the catheter access were collected. Factors assessed for proximal tortuosity included cervical internal carotid artery (ICA) tortuosity (defined as a 90° turn, hairpin turn, or corkscrew loop) and cavernous ICA grade [9] . The data are presented as counts and means. Statistical analysis of counts was done using χ 2 tests and statistical analysis of means was conducted using the Student t test or one-way analysis of variance.
Endovascular Procedure
The patients were preoperatively treated with 325 mg aspirin and 75 mg clopidogrel daily for at least 1 week prior to the treatment. Platelet inhibition testing was not routinely performed. Systemic anticoagulation with heparin was done during the embolization. Through an 8-Fr femoral short sheath, a triaxial system was used for all procedures, consisting of an 8-Fr-long guide sheath, a DIC, and a 0.027′′-inner diameter (ID) microcatheter.
Details regarding the PED Flex procedure have been previously described [10] [11] [12] . In general, the intended target of the Syphontrak position was just proximal to the aneurysm. For instance, in the case of a paraophthalmic ICA aneurysm, the intended catheter target would be the anterior genu/horizontal cavernous segment of the ICA. The Syphontrak would then be withdrawn proximally as needed during PED deployment. Although the catheter targets were established at the time of the case, the overall data analysis for this study was done retrospectively.
Results
Patient and Aneurysm Characteristics
During the time course of the institutional study (August 2016 to June 2017), 47 consecutive patients with cerebral aneurysms were treated with a PED Flex using the Syphontrak catheter (Table 1) by the senior author. Forty (85%) of the 47 patients were female. The mean patient age was 57.3 ± 11.6 years (range 25-80). Ten patients (21%) had previously treated aneurysms, with coiling in 6 cases, clipping in 1 case, flow diversion in 2 cases, and cotton wrapping in 1 case. The average aneurysm size was 4.8 ± 2.7 mm, with a range of 2-14 mm. Forty-five (96%) of the 47 aneurysms were classified as small (2-10 mm) and the remainder were considered large (11-24 mm).
All cases of Syphontrak utilization were in the anterior circulation ( Table 2 ). The most common sites of PED Flex deployment were along the ICA. Paraophthalmic and ophthalmic aneurysms accounted for 33/47 cases (70%). There were 5 cases of supraclinoid/posterior communicating aneurysms (11%), 1 petrous aneurysm (2%), 1 cavernous aneurysm (2%), and 1 aneurysm at the ICA termination (2%). In addition to ICA aneurysms, 3 (6%) anterior communicating artery region aneurysms and 3 (6%) middle cerebral artery aneurysms were treated. 
Equipment Utilized
The Syphontrak (Codman Neuro) was the DIC utilized in the triaxial system for all 47 cases (Fig. 1) . The 6-Fr-long guide sheaths used included the AXS Infinity 0.088″ (Stryker Neurovascular) in 46 cases and the Neuron Max 0.088″ (Penumbra, Alameda, CA, USA) in 1 case. The VIA27 (MicroVention/Sequent Medical) was the PED Flex delivery microcatheter used in 46 cases and the Phenom 27 microcatheter was used in 1 case (Medtronic Neurovascular).
Vessel Tortuosity and Catheter Positions
Significant cervical ICA tortuosity defined as a 90° turn, hairpin turn, or corkscrew loop was encountered in 11/47 (23%) of the cases (Table 3 ). Figure 2 demonstrates selected examples of cervical tortuosity successfully navigated by the Syphontrak. The cavernous carotid grade was also assigned to each case according to a previously published classification system [9] . This anatomical grading system has been established as a predictor of PED Flex case complexity. Minimal cavernous ICA tortuosity (types IA and IB) was observed in 23/47 (49%) of the cases, while moderate-to-severe cavernous ICA tortuosity (types II-IV) was present in 24/47 cases (51%). Figure 3 demonstrates an example of intracranial cavernous tortuosity easily navigated with the Syphontrak without vessel distortion. In all but one case, the Syphontrak was positioned beyond the petrous segment of the ICA. The most common positions of the Syphontrak for intracranial support were as follows: proximal cavernous (defined as within the posterior genu or horizontal segments; n = 22; 47%), distal cavernous (defined as the anterior genu; n = 19; 40%), and supraclinoid (n = 3; 6%). In 2 cases, the Syphontrak was tracked into the proximal M1 for treatment of distal middle cerebral artery aneurysms. 
Procedural Characteristics and Complications
All 47 cases were completed with successful PED Flex implantation. The procedural details are highlighted in Table 4 . In 1 case, a 4 × 12 mm PED Flex was foreshortened too much during deployment and no longer covered the neck of the intended aneurysm; as such, this device was thought to be of insufficient length and thus was recaptured completely and removed. A new 4 × 14 mm device was then introduced and deployed without incident. The mean fluoroscopy time was 36.6 ± 14.8 min and the mean radiation exposure was 1,876 ± 913 mGy. Verapamil infusion was administered intra-arterially for vasospasm prophylaxis or treatment in 12/47 cases (26%). Balloon angioplasty was utilized in 12 cases (26%) to improve vessel wall apposition of the flow diverter after deployment. In addition, coil embolization was performed in 3 cases at the time of PED Flex implantation. Intra-arterial abciximab was administered in 3 cases of in situ thrombosis due to platelet aggregation immediately after PED Flex deployment.
The majority of the patients were discharged home (98%) after an average length of stay of 1.4 days (range 1-5) ( Table 5 ). There were no access-related complications such as iatrogenic dissection or groin hematoma. There were no periprocedural mortalities, intracranial hemorrhage, subarachnoid hemorrhage, or major strokes in this cohort. One minor stroke and 3 transient deficits were noted. 
Discussion
In this report, we describe our experience with the Syphontrak catheter in treatment of anterior circulation cerebral aneurysms by Pipeline flow diversion. Despite the presence of cervical ICA tortuosity in 23% (11/47) and moderate-to-severe cavernous ICA tortuosity (cavernous ICA grades II-IV) in 51% (24/27) of the cases, the Syphontrak catheter navigated successfully to the intended locations and PED Flex implantation was completed in all cases. Intra-arterial verapamil infusion for treatment or prophylaxis of catheter-related vasospasm was only utilized in 26% (12/47) of the cases.
The flow diversion revolution with the PED Flex has changed the practice paradigm for many cerebral aneurysm treatments [13] and with it the common catheter components of the coaxial support system [14] . The larger 0.027″-ID delivery microcatheters for flow diverter deployment and the relatively increased push and pull forces used to deploy such devices have led to the routine use of a new class of support catheters called ICs or DICs. The Navien catheter was introduced close to the launch of the PED in the USA, and since then several other ICs/DICs have emerged, including the AXS Catalyst 5, Sofia, and now the Syphontrak [1, 5, 8] . These 5-Fr catheters were designed for use within a triaxial platform system with a long guide sheath [15] . Table 6 compares the general specifications for several 5-Fr DICs commonly used in PED Flex deployment.
The Syphontrak catheter is the newest of the available DICs. This catheter is designed with a proximal stainless steel braid that ends in a nitinol coil for a combination of proximal strength and distal flexibility. The distal flexible zone is 18 cm in length. The true distal tip is rounded and tapered to facilitate atraumatic movement. On the proximal end, the acrylic Luer lock hub is short, giving an increasing functional microcatheter working length, particularly when combined with the included short rotating hemostatic valve.
Mean length of stay ± SD (range), days 1.38±0.795 (1-5) Discharge to home, n (%) 46 (98) Mortality, n (%)
SAH, subarachnoid hemorrhage; ICH, intracranial hemorrhage. The Syphontrak outer diameter (OD) is 6 Fr (0.076″) proximally and tapers to 5 Fr (0.069″) distally. The larger OD allows for added stability and pushability of the catheter. Despite the larger overall OD, the Syphontrak remained easy to navigate to distal intracranial positions in each of the cases of this series. We routinely positioned the Syphontrak by tracking it over a 0.027″ microcatheter and a 0.016″ microwire. This method, along with the rounded distal tip of the Syphontrak, helps reduce "step-off" and allows for successful atraumatic navigation through the vasculature. We routinely positioned the Syphontrak in the distal cavernous ICA and even tracked the catheter to the supraclinoid ICA and M1 without evidence of vessel injury or significant flow-limiting vasospasm (Fig. 4) .
The main feature that distinguishes the Syphontrak from the other DICs currently available on the market is its ID. The ID of the Syphontrak is 0.062″ proximally and 0.060″ distally. Compared to the other 5-Fr distal ICs/DICs, the Syphontrak provides the largest ID with its 0.060″ specification (Table 6 ). This extra space allows for an improved flush rate and better contrast injection through the DIC. The better contrast injections allow for enhanced digital subtraction angiography runs, roadmaps, and "puffing" to check vessel patency and flow (Fig. 3) . For aneurysm treatments requiring a larger delivery microcatheter, such as the Surpass platform, this larger ID provides a significant advantage [16] .
In addition to serving as a support system, the DIC can also be used as an instrument or advanced technique for augmenting PED Flex deployment [8, 11] . As with the Navien and Catalyst 5, the Syphontrak has the trackability and pushability for such advanced maneuvers despite its overall larger OD. For example, the Syphontrak can be tracked over the 0.027″ microcatheter with ease to bump and foreshorten the proximal end of the PED Flex in order to improve vessel wall apposition if needed. The DIC also can be tracked over the microcatheter into the PED Flex for endoluminal access. Endoluminal access is advantageous in cases needing multi-device deployments or balloon angioplasty to postprocess a malapposed PED Flex implant. Furthermore, the larger ID of the Syphontrak facilitates intra-DIC deployment of the proximal PED Flex in cases with a tortuous cavernous anatomy [11] .
We have previously reported our institutional experience with the AXS Catalyst 5 [8] and Navien DICs [5] . Table 7 highlights the case complexity of the comparison between those that utilized the Syphontrak and those that used the other DICs. There was a statistically significant difference in the proportion of cases with cervical tortuosity treated with the Navien (44%) compared to the Syphontrak (23%) or Catalyst 5 (26%), which is likely a reflection of our earlier experience with the PED in mostly "on-label" cases of older patients with a more complex proximal anatomy. There was no statistically significant difference in cavernous ICA grading between the three cohorts. Compared to our earlier experiences with the Navien, both the Catalyst 5 and the Syphontrak cases utilized statistically significantly less fluoroscopy time, despite similar numbers and sizes of Pipeline devices. Verapamil was utilized in 26% of the cases with the Syphontrak series compared to 3.8% in the Navien series and 14% in the Catalyst 5 series. The increased use of verapamil was multifactorial. This reflects our changing institutional practice patterns to utilize IA vasodilation prophylactically rather than as a reactive measure to vasospasm. For the Syphontrak, prophylactic IA verapamil was frequently used, knowing that the catheter's OD is larger and that the catheter tip is to be intentionally advanced to very distal locations. Despite the increased usage of IA verapamil, there were no catheter-related complications and no significant changes in overall procedural complications and outcomes. This finding again highlights that despite the fact that the Syphontrak has a larger OD, it still can be safely navigated to more distal locations without increased adverse complications. The primary limitations of the Syphontrak arise from its larger proximal OD. Although this feature of the catheter adds support and pushability, it can reduce the quality of contrast injections through the long guide sheath when the Syphontrak is fully advanced or "hubbed." Additionally, the larger OD of the Syphontrak excludes its use in cases requiring direct 5-Fr access, where the DIC is advanced directly through a short 5-Fr sheath. Direct carotid punctures for severe proximal tortuosity and posterior circulation cases needing radial or brachial access fall into this category [17] . In these circumstances, the Navien 058 remains the catheter of choice. The general limitation of this series is the mostly retrospective data collection and review. 
